What is Platelet-Derived Growth Factor Beta Polypeptide, and How Does It Help Stimulate New Hair Growth?

Platelet-Derived Growth Factor Beta Polypeptide (PDGF-BB) is a naturally occurring protein that plays a central role in the repair and regeneration of human tissues. It belongs to a family of signaling molecules called growth factors, which are responsible for communication between cells. PDGF-BB is secreted primarily by platelets, endothelial cells, and fibroblasts, all of which are involved in healing and tissue maintenance. Its function is to activate other cells to proliferate, migrate, and repair damaged structures, particularly in the skin and connective tissues. When released in a wound or damaged area, PDGF-BB stimulates the formation of new blood vessels and enhances the survival of cells involved in tissue regeneration.

Within the hair follicle, PDGF-BB is described as interacting with the dermal papilla—a structure located at the base of the follicle that regulates hair growth. The dermal papilla controls whether the follicle remains in a resting phase (telogen) or enters an active growth phase (anagen). Laboratory work reports that, by binding to the PDGF receptor beta (PDGFR-β) on the surface of dermal papilla cells, PDGF-BB initiates a chain of cellular signals associated with cell division, increased vascularization, and a healthier follicular environment.

Mechanisms and Biological Effects

To understand why PDGF-BB matters in hair biology, it is useful to examine how it affects the microenvironment of the scalp. Hair follicles are highly dependent on their surrounding blood supply and the activity of dermal papilla cells. PDGF-BB is reported to contribute to both by stimulating angiogenesis—the growth of new capillaries—and by enhancing communication between follicular cells and the extracellular matrix. The extracellular matrix is a network of proteins that provides structural and biochemical support to cells. Studies describe that when PDGF-BB binds to its receptor, it triggers signaling pathways such as PI3K/Akt and MAPK, both of which are associated with cell survival and growth.

Evidence from animal models suggests that PDGF signaling can induce the transition from the resting to the growing phase of the hair cycle. In a 2006 mouse study, Tomita, Akiyama and Shimizu injected PDGF isoforms into the skin of telogen-phase mice and reported that PDGF induced and maintained the anagen phase of the hair follicles, with PDGF-BB among the isoforms tested (Tomita et al., 2006, Journal of Dermatological Science). These results cannot be extrapolated to humans, but they are the basis for the idea that PDGF signaling may be part of the biology that reactivates dormant follicles.

Evidence from Human Studies

The human evidence surrounding PDGF-BB primarily arises from research into platelet-rich plasma (PRP) therapies. PRP is a concentrated preparation of platelets derived from a patient's own blood and is rich in growth factors, including PDGF-BB. Some clinical studies report that PRP injections into the scalp increase hair density and thickness, but no study has isolated PDGF-BB as the active factor. A randomized placebo-controlled trial published in Stem Cells Translational Medicine in 2015 studied 23 men with androgenetic alopecia in a half-head design, giving three PRP sessions about 30 days apart, and reported an increase in hair count and hair density on the treated side at the end of the treatment cycle (Gentile et al., 2015). The authors note that PRP contains multiple growth factors—such as VEGF (Vascular Endothelial Growth Factor) and IGF-1 (Insulin-like Growth Factor 1)—so the results cannot be attributed to PDGF-BB alone.

A commonly noted limitation of PRP studies is their short duration and small sample size. Most published trials run for months rather than years and include a few dozen participants, which restricts the strength of their conclusions. Additionally, variations in how PRP is prepared and injected mean that PDGF-BB concentrations can differ significantly between studies. This lack of standardization complicates any attempt to attribute results specifically to PDGF-BB.

The Role of PDGF-BB Compared with Other Growth Factors

PDGF-BB is part of a complex biochemical network. It is described as working alongside other growth factors that also affect hair regeneration, such as VEGF, which promotes blood vessel formation, and EGF, which accelerates cell proliferation in the epidermis. Reviews of follicle biology place PDGF signaling close to the dermal papilla's role in organizing and sustaining the hair cycle, and connect it to follicle vascularization. Those same reviews report a lack of consistent human data and call for larger controlled trials before any conclusion is drawn.

Criticism and Current Limitations

Several caveats apply when PDGF-BB is discussed as a treatment for hair loss. The majority of data come from preclinical studies or from combined-growth-factor therapies such as PRP. There is no published human trial of isolated PDGF-BB for hair loss. Hair growth is also influenced by hormones, genetics, inflammation, and scalp health, so no single molecule is likely to offer a comprehensive solution.

No PDGF-based formulation is approved for hair restoration. PDGF-BB is available as an approved medicine only for wound healing—becaplermin gel, a recombinant PDGF-BB product, is approved for lower-extremity diabetic neuropathic ulcers and carries a boxed warning about malignancy with repeated use. On current evidence, the use of PDGF-BB in hair loss management is experimental: it is a line of research, not a clinically validated therapy.

Research suggests that PDGF-BB may play a supportive role in reactivating dormant hair follicles and promoting the anagen phase of the hair cycle. However, the scientific evidence available today is preliminary, with most results derived from small-scale or indirect studies. For individuals experiencing hair loss, PDGF-BB represents an intriguing but still unproven component of the broader field of regenerative medicine. PRP and other growth-factor injections are medical procedures: talk to a doctor or dermatologist before starting, stopping or combining them, and ask what evidence applies to your own pattern of hair loss.

References

Gentile, P., Garcovich, S., Bielli, A., Scioli, M. G., Orlandi, A., & Cervelli, V. (2015). The effect of platelet-rich plasma in hair regrowth: A randomized placebo-controlled trial. Stem Cells Translational Medicine, 4(11), 1317–1323. Retrieved from https://pubmed.ncbi.nlm.nih.gov/26400925/

Tomita, Y., Akiyama, M., & Shimizu, H. (2006). PDGF isoforms induce and maintain anagen phase of murine hair follicles. Journal of Dermatological Science, 43(2), 105–115. Retrieved from https://pubmed.ncbi.nlm.nih.gov/16725313/